Standard Engineering Technology Limited

Standard Glass Lining Technology Limited is undergoing a significant transformation, evolving from an independent equipment manufacturer to a multidisciplinary precision engineering company. The company proposes to change its name to Standard Engineering Technology Limited, a name that better reflects its expanded capabilities across design, fabrication, automation, installation, commissioning, and validation. This strategic shift aims to offer complete concept-to-commissioning solutions across pharmaceutical, chemical, biotechnology, food, and beverage industries.

For the first half of FY26, the company reported a total income of INR 366 crores, an EBITDA of INR 69 crores, and a PAT of INR 42 crores. The Q2 FY26 EBITDA margin experienced a decline to 16%, down from 17% QoQ and 20% YoY. This margin pressure was primarily attributed to the deferral of INR 45 crores worth of export orders from H1 to H2 FY26, caused by delays in customer inspections. Management anticipates a stronger second half as these deferred orders are expected to be executed.

SETL is actively pursuing strategic acquisitions to bolster its engineering and solution offerings. The company announced the acquisition of a 51% stake in C2C Engineering Private Limited for INR 12.25 crores. This acquisition is crucial for integrating process design, mechanical, civil, HVAC, electrical, and instrumentation expertise, enabling SETL to deliver comprehensive concept-to-commissioning solutions. Additionally, the prior acquisition of Scigenics has strengthened the company's presence in the bioprocess and fermentation systems sector.

The company has achieved a technological breakthrough with its shell and tube glass-lined heat exchangers, developed in collaboration with Japanese partner GL Hakko. These products have received strong customer appreciation, with orders already booked until March. SETL plans to invest INR 10-15 crores to establish manufacturing for these heat exchangers in India, targeting a PAT margin of 15-18%. The estimated market size for these products is INR 2,000 crores, indicating a significant growth opportunity.

SETL has ambitious capex plans to expand its manufacturing capacity. A greenfield capex of INR 120-150 crores is planned for the first phase, involving the construction of a 6-lakh-square-feet facility on 36 acres. This new unit will feature enhanced capabilities, including a 100-ton crane capacity and 100 mm thick fabrication, and is expected to add another INR 2,000 crores in revenue potential. The project is currently awaiting government permissions, with completion anticipated in 14-18 months. Current overall capacity utilization stands at almost 70%, with glass lining at 50%.

Demand from the pharma sector remains robust, primarily driven by large clients who are continuing their capex investments. However, small and medium pharma clients are facing challenges such as cash flow issues and price pressures, leading to a slowdown in their capex. The agrochemicals sector is also showing an increasing demand, with SETL securing significant orders from two major clients. The company's top 10 clients contribute approximately 45% of its total revenue, highlighting a reliance on a concentrated base of large customers.